APITOPE

apitope-logo

Apitope is a biotech company focused on the discovery and development of disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Gravesโ€™ disease, Factor VIII intolerance and uveitis. The company, whose first product candidate is licensed to Merck Serono, will now progress its remaining portfolio of product candidates developed with its proprietary platform technology.

#SimilarOrganizations #People #Financial #Website #More

APITOPE

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2002-01-01

Address:
Bristol, Bristol, City Of, United Kingdom

Country:
United Kingdom

Website Url:
http://www.apitope.com

Total Employee:
11+

Status:
Active

Total Funding:
22 M EUR

Technology used in webpage:
Person Schema Gravatar Profiles Gravity Forms British Server Location


Similar Organizations

aerogen-logo

Aerogen

Aerogen is a medical device and drug delivery company.

calimmune-logo

Calimmune

Calimmune is a clinical-stage gene therapy company.

immunos-therapeutics-logo

ImmunOs Therapeutics

ImmunOs Therapeutics is a clinical-stage biotechnology company.

kbp-biosciences-logo

KBP Biosciences

A multinational clinical stage biotechnology company.

neumora-therapeutics-logo

Neumora Therapeutics

Neumora Therapeutics operates as a clinical-stage biotechnology company.

not_available_image

SA Biotech

SA Biotech is a Healthcare company.

Current Employees Featured

david-wraith_image

David Wraith
David Wraith Chief Scientific Officer & Founder @ Apitope
Chief Scientific Officer & Founder

keith-f-martin_image

Keith F Martin
Keith F Martin Chief Executive Officer @ Apitope
Chief Executive Officer

Founder


david-wraith_image

David Wraith

Investors List

limburgse-reconversie-maatschappij_image

Limburgse Reconversie Maatschappij

Limburgse Reconversie Maatschappij investment in Series B - Apitope

vesalius-biocapital-partners_image

Vesalius Biocapital Partners

Vesalius Biocapital Partners investment in Series B - Apitope

pmv-pharmaceutcals-inc_image

PMV Pharmaceuticals

PMV Pharmaceuticals investment in Series B - Apitope

wyvern-seed-fund_image

Wyvern Seed Fund

Wyvern Seed Fund investment in Series B - Apitope

arthurian-life_image

Arthurian Life Sciences

Arthurian Life Sciences investment in Series B - Apitope

vesalius-biocapital-partners_image

Vesalius Biocapital Partners

Vesalius Biocapital Partners investment in Series A - Apitope

vinnof_image

Vinnof

Vinnof investment in Series A - Apitope

Official Site Inspections

http://www.apitope.com

  • Host name: 176-58-126-104.ip.linodeusercontent.com
  • IP address: 176.58.126.104
  • Location: London United Kingdom
  • Latitude: 51.5164
  • Longitude: -0.093
  • Timezone: Europe/London
  • Postal: EC2V

Loading ...

More informations about "Apitope"

Apitope - Crunchbase Company Profile & Funding

Apitope is a biotech company focused on the discovery and development of disease modifying therapies for autoimmune and allergic diseases, including โ€ฆSee details»

Apitope 2025 Company Profile: Valuation, Investors, Acquisition

Information on acquisition, funding, cap tables, investors, and executives for Apitope. Use the PitchBook Platform to explore the full profile.See details»

Apitope - Products, Competitors, Financials, Employees, โ€ฆ

Apitope is a European biotech company focused on the discovery and development of revolutionary disease modifying therapies for autoimmune and allergic diseases, including โ€ฆSee details»

Apitope - VentureRadar

"Apitope International NV is a biopharmaceutical company with its head office in Diepenbeek, Belgium, and a subsidiary in Bristol, United Kingdom. The company develops trail-blazing โ€ฆSee details»

Apitope Company Profile - Office Locations, Competitors ... - Craft

Apitope has 5 employees across 2 locations and $26.22 m in total funding,. See insights on Apitope including office locations, competitors, revenue, financials, executives, subsidiaries โ€ฆSee details»

Apitope - Funding, Financials, Valuation & Investors - Crunchbase

In funding over 3 rounds. Their latest funding was raised on Sep 29, 2015 from a Series B round. Apitope is funded by 6 investors. Limburgse Reconversie Maatschappij and Vesalius โ€ฆSee details»

Apitope - LinkedIn

Apitope | 1,521 followers on LinkedIn. Apitope is a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapeutics targeting the immunological basis of ...See details»

Apitope - Company Profile - Tracxn

Feb 25, 2025 Apitope - Developer of therapeutic peptides for the treatment of autoimmune and allergic diseases. Raised a total funding of $26.6M over 2 rounds from 9 investors. Founded โ€ฆSee details»

Apitope International N.V. - Life-Sciences-Europe.com

Jan 13, 2009 Apitope is a clinical stage biotech company that develops potential first-in-class antigen-specific immunotherapies targeting autoimmune diseases. Apitope uses its novel, โ€ฆSee details»

Apitope โ€“ World-leading clinical-stage biotech firm, โ€ฆ

October Edition 2020 Apitope โ€“ World-leading clinical-stage biotech firm, developing antigen-specific immunotherapeutics for autoimmune diseasesSee details»

Home - Epitopea

Feb 19, 2025 Epitopea is a transatlantic cancer immunotherapeutics company based in Montreal, Canada and Cambridge, UK. Our proprietary CryptoMap TM platform, created and optimized by Drs. Claude Perreault and Pierre Thibault โ€ฆSee details»

Apitope International NV - Diepenbeek, Belgium - bionity.com

Jun 11, 2015 Apitope is a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapeutics targeting the immunological basis of autoimmune โ€ฆSee details»

Apitope CEO and Key Executive Team - Craft.co

Apitope's Chief Executive Officer is Hayley French. Other executives include Stéphane Verdood, Non-Executive Director; Chairman of the Board; Liselotte Jansson, Chief Research Officer and โ€ฆSee details»

Apitopeโ€™s Competitors, Revenue, Number of Employees, Funding โ€ฆ

Apitopeโ€™s Profile, Revenue and Employees. Apitope develops antigen-specific immunotherapies for the treatment of autoimmune diseases. Apitopeโ€™s primary competitors include Kineta, โ€ฆSee details»

Apitope International Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Apitope International of Diepenbeek, Limburg. Get the latest business insights from Dun & Bradstreet.See details»

Interview with Keith Martin, CEO, Apitope

Mar 13, 2012 Apitopeโ€™s research and success is based on its High Speed Technology Platform that uses solubleโ€ฆSee details»

Apitope Treatment Approach Published in Nature Communications

Sep 4, 2014 Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today โ€ฆSee details»

Apitope | VentureRadar

Apitope International NV is a biopharmaceutical company with its head office in Diepenbeek, Belgium, and a subsidiary in Bristol, United Kingdom. The company develops trail-blazing โ€ฆSee details»

Rope Access Services Melbourne | API Rope Access

Book the best Rope Access Services Melbourne has to offer. Elevate your project with API Rope Access now and get high quality services. Get a free quote today!See details»

Apitope - LinkedIn

Apitope is a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapeutics targeting the immunological basis of autoimmune diseases. We use our โ€ฆSee details»

linkstock.net © 2022. All rights reserved